Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effects of Otago Exercise Program on serum Interleukin-6 level in older women [with consumer summary]
Gde Agung Mahendra ID, Subadi I, Wardhani IL, Satyawati R, Alit Pawana IP, Melaniani S
Annals of Medicine and Surgery 2022 Jun;78:103733
clinical trial
4/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Otago Exercise Program (OEP) has been demonstrated to minimize the risk of falling in older adults by improving muscular strength and balance. Meanwhile, reduced IL-6 level serves as a biomarker of regular physical activity. OBJECTIVE: Analyzing OEP effect on decreased IL-6 level in elderly women. METHODS: This study used a randomized control trial design from October 2020 to May 2021. 26 participants were divided into a treatment group (13 participants) and a control group (13 participants). The treatment group received OEP for 8 weeks, in which the OEP was carried out 3 times during the first week. On the other hand, the control group did not get intervention. The IL-6 level was measured 2 times, before and after OEP. The measurement results were analyzed using paired t-test and independent t-test, which were declared significant if p < 0.05. RESULTS: The participants' average IL-6 level at pretest and posttest was 4.77 +/- 1.71 pg/mL and 4.57 +/- 1.74 pg/mL, respectively. The IL-16 level of the treatment group at pretest and posttest was 4.22 +/- 1.72 pg/mL and 3.97 +/- 1.67 pg/mL, respectively (t = 1.058; 95% CI -0.770 -0.267; p = 0.311). Meanwhile, the IL-6 level of the control group at pretest and posttest was 5.30 +/- 1.59 pg/mL and 5.16 +/- 1.65 pg/mL, respectively (t = 0.382; 95% CI -0.969 -0.680; p = 0.709). The DELTAIL-6 level in the treatment and control group was -0.25 +/- 0.85 pg/mL and -0.14 +/- 1.36 pg/mL, respectively (t = 0.240; 95% CI -1.030 -0.815; p = 0.813). CONCLUSION: The OEP didn't lower serum IL-6 levels after eight weeks.

Full text (sometimes free) may be available at these link(s):      help